WO2013032953A3 - Development and use of fluorescent probes of unbound bilirubin - Google Patents
Development and use of fluorescent probes of unbound bilirubin Download PDFInfo
- Publication number
- WO2013032953A3 WO2013032953A3 PCT/US2012/052395 US2012052395W WO2013032953A3 WO 2013032953 A3 WO2013032953 A3 WO 2013032953A3 US 2012052395 W US2012052395 W US 2012052395W WO 2013032953 A3 WO2013032953 A3 WO 2013032953A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- probes
- development
- fluorescent probes
- unbound bilirubin
- labeled
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/728—Bilirubin; including biliverdin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/145555—Hetero-N
- Y10T436/146666—Bile pigment
Abstract
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2014002051A MX347754B (en) | 2011-08-26 | 2012-08-24 | Development and use of fluorescent probes of unbound bilirubin. |
EP19159898.6A EP3598139A1 (en) | 2011-08-26 | 2012-08-24 | Development and use of fluorescent probes of unbound bilirubin |
DK12827317.4T DK2748615T3 (en) | 2011-08-26 | 2012-08-24 | Development and use of unbound bilirubin fluorescent probes |
JP2014527346A JP6104913B2 (en) | 2011-08-26 | 2012-08-24 | Development and use of fluorescent probes for unbound bilirubin |
CN201280041789.4A CN104220877B (en) | 2011-08-26 | 2012-08-24 | The development and application of the fluorescence probe of unconjugated bilirubin |
AU2012300319A AU2012300319B8 (en) | 2011-08-26 | 2012-08-24 | Development and use of fluorescent probes of unbound bilirubin |
US14/238,144 US9529003B2 (en) | 2011-08-26 | 2012-08-24 | Development and use of fluorescent probes of unbound bilirubin |
EP12827317.4A EP2748615B1 (en) | 2011-08-26 | 2012-08-24 | Development and use of fluorescent probes of unbound bilirubin |
CA2846106A CA2846106C (en) | 2011-08-26 | 2012-08-24 | Development and use of fluorescent probes of unbound bilirubin |
ES12827317T ES2733974T3 (en) | 2011-08-26 | 2012-08-24 | Development and use of unbound bilirubin fluorescent probes |
US15/354,188 US10295551B2 (en) | 2011-08-26 | 2016-11-17 | Development and use of fluorescent probes of unbound bilirubin |
AU2017208236A AU2017208236B2 (en) | 2011-08-26 | 2017-07-25 | Development and use of fluorescent probes of unbound bilirubin |
US16/366,143 US11029320B2 (en) | 2011-08-26 | 2019-03-27 | Development and use of fluorescent probes of unbound bilirubin |
AU2019206014A AU2019206014B2 (en) | 2011-08-26 | 2019-07-16 | Development and use of fluorescent probes of unbound bilirubin |
CY20191100805T CY1122022T1 (en) | 2011-08-26 | 2019-07-29 | DEVELOPMENT AND USE OF FLUORESCENT CHOLERYTHRIN BINDING DETECTORS |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161527849P | 2011-08-26 | 2011-08-26 | |
US61/527,849 | 2011-08-26 |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19159898.6A Previously-Filed-Application EP3598139A1 (en) | 2011-08-26 | 2012-08-24 | Development and use of fluorescent probes of unbound bilirubin |
US14/238,144 A-371-Of-International US9529003B2 (en) | 2011-08-26 | 2012-08-24 | Development and use of fluorescent probes of unbound bilirubin |
US15/354,188 Continuation US10295551B2 (en) | 2011-08-26 | 2016-11-17 | Development and use of fluorescent probes of unbound bilirubin |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2013032953A2 WO2013032953A2 (en) | 2013-03-07 |
WO2013032953A3 true WO2013032953A3 (en) | 2013-08-08 |
WO2013032953A8 WO2013032953A8 (en) | 2014-10-09 |
Family
ID=47757131
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/052395 WO2013032953A2 (en) | 2011-08-26 | 2012-08-24 | Development and use of fluorescent probes of unbound bilirubin |
Country Status (12)
Country | Link |
---|---|
US (3) | US9529003B2 (en) |
EP (2) | EP3598139A1 (en) |
JP (3) | JP6104913B2 (en) |
CN (2) | CN104220877B (en) |
AU (3) | AU2012300319B8 (en) |
CA (1) | CA2846106C (en) |
CY (1) | CY1122022T1 (en) |
DK (1) | DK2748615T3 (en) |
ES (1) | ES2733974T3 (en) |
MX (2) | MX347754B (en) |
PT (1) | PT2748615T (en) |
WO (1) | WO2013032953A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2891820A1 (en) * | 2012-11-16 | 2014-05-22 | Iba Gmbh | Streptavidin muteins and methods of using them |
US9957308B2 (en) * | 2013-02-28 | 2018-05-01 | Riken | Method for detecting bilirubin using a fluorescent protein |
EP3077827B1 (en) | 2013-12-03 | 2023-11-01 | Kleinfeld, Alan M. | Determination of the unbound free fatty acid profiles in biological and industrial specimens |
US20160146838A1 (en) * | 2014-11-20 | 2016-05-26 | Jean Ronald Brisard | System and method for ebola detection |
CN104819981B (en) * | 2015-05-16 | 2017-11-21 | 山东耀华医疗器械股份有限公司 | A kind of urinary fractions measuring instrument |
WO2018190357A1 (en) * | 2017-04-11 | 2018-10-18 | 国立研究開発法人産業技術総合研究所 | Method for immobilizing lectin |
WO2019195317A1 (en) * | 2018-04-03 | 2019-10-10 | Neometrix Dx | Methods and devices for assessing in vivo toxic levels of bilirubin and diagnosing increased risk of bilirubin neurotoxicity |
CN111334079A (en) * | 2018-12-18 | 2020-06-26 | 中国科学院大连化学物理研究所 | Full-spectrum high-brightness and high-stability fluorescent dye and synthesis and application thereof |
KR20220104676A (en) * | 2019-08-30 | 2022-07-26 | 알랜 클레인펠드 | One Step Methods, Kits and Systems for Determination of Concentrations of Unbound Bilirubin in Biological Fluids |
CN111239094B (en) * | 2020-03-13 | 2022-08-26 | 河南中医药大学 | Sensitive detection method of alkaline phosphatase |
CN113238041B (en) * | 2021-01-13 | 2024-01-16 | 军事科学院军事医学研究院环境医学与作业医学研究所 | Beta-cyclodextrin modification-based immune biological bar code sensitization probe and method for rapidly detecting atrazine |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050244864A1 (en) * | 2004-03-22 | 2005-11-03 | Kleinfeld Alan M | Development and use of fluorescent probes of unbound analytes |
US20100298162A1 (en) * | 2008-01-18 | 2010-11-25 | Ffa Sciences, Llc | Development and use of cysteine-labeled fluorescent probes of unbound analytes |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5470714A (en) | 1989-12-12 | 1995-11-28 | Lidak Pharmaceuticals | One-step free fatty acid determination method |
US6444432B1 (en) | 1997-06-13 | 2002-09-03 | Alan M. Kleinfeld | Method of detection of cardiac ischemia using fatty acid binding protein |
ATE330224T1 (en) | 2000-08-15 | 2006-07-15 | Discerna Ltd | FUNCTIONAL PROTEIN ARRAY |
US20060257938A1 (en) * | 2005-05-10 | 2006-11-16 | Kleinfeld Alan M | Method of screening for drugs that block ligand binding to a lipid binding protein |
WO2008060841A2 (en) * | 2006-10-27 | 2008-05-22 | Ffa Sciences, Llc | Use of probes for unbound metabolites |
-
2012
- 2012-08-24 CA CA2846106A patent/CA2846106C/en active Active
- 2012-08-24 DK DK12827317.4T patent/DK2748615T3/en active
- 2012-08-24 EP EP19159898.6A patent/EP3598139A1/en active Pending
- 2012-08-24 PT PT12827317T patent/PT2748615T/en unknown
- 2012-08-24 AU AU2012300319A patent/AU2012300319B8/en active Active
- 2012-08-24 EP EP12827317.4A patent/EP2748615B1/en active Active
- 2012-08-24 US US14/238,144 patent/US9529003B2/en active Active
- 2012-08-24 CN CN201280041789.4A patent/CN104220877B/en active Active
- 2012-08-24 MX MX2014002051A patent/MX347754B/en active IP Right Grant
- 2012-08-24 CN CN201711257192.4A patent/CN108051584B/en active Active
- 2012-08-24 ES ES12827317T patent/ES2733974T3/en active Active
- 2012-08-24 JP JP2014527346A patent/JP6104913B2/en active Active
- 2012-08-24 WO PCT/US2012/052395 patent/WO2013032953A2/en active Application Filing
-
2014
- 2014-02-20 MX MX2019010563A patent/MX2019010563A/en unknown
-
2016
- 2016-11-17 US US15/354,188 patent/US10295551B2/en active Active
-
2017
- 2017-03-01 JP JP2017038572A patent/JP6694403B2/en active Active
- 2017-07-25 AU AU2017208236A patent/AU2017208236B2/en active Active
-
2019
- 2019-03-11 JP JP2019043964A patent/JP6847141B2/en active Active
- 2019-03-27 US US16/366,143 patent/US11029320B2/en active Active
- 2019-07-16 AU AU2019206014A patent/AU2019206014B2/en active Active
- 2019-07-29 CY CY20191100805T patent/CY1122022T1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050244864A1 (en) * | 2004-03-22 | 2005-11-03 | Kleinfeld Alan M | Development and use of fluorescent probes of unbound analytes |
US20100298162A1 (en) * | 2008-01-18 | 2010-11-25 | Ffa Sciences, Llc | Development and use of cysteine-labeled fluorescent probes of unbound analytes |
Non-Patent Citations (1)
Title |
---|
HUBER, A. H. ET AL.: "Fatty acid-specific fluorescent probes and their use in resolving mixtures of unbound free fatty acids in equilibrium with albumin", BIOCHEMISTRY, vol. 45, no. 48, 5 December 2006 (2006-12-05), pages 14263 - 14274, XP055081885 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013032953A3 (en) | Development and use of fluorescent probes of unbound bilirubin | |
WO2013190075A3 (en) | Specific biomarkers for hepatocellular carcinoma (hcc) | |
HK1208071A1 (en) | Multi-application approach for photometric determination of an analyte in a fluid sample on an automated analyzer | |
EA201600085A1 (en) | KIT FOR DETECTION OF SOYO SYNT SYNT0H2 EVENT | |
WO2010065568A3 (en) | METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95 | |
BRPI1013688A8 (en) | IL-17 BINDING PROTEINS. | |
MX367366B (en) | Compositions and methods for diagnosing thyroid tumors. | |
GB0606776D0 (en) | Predictive biomarkers for chronic allograft nephropathy | |
WO2012102535A3 (en) | Composition for detecting proteins containing tyrosine oxide-coupled biomaterial | |
WO2008125747A3 (en) | Fluorescent emulsions for optical imaging | |
WO2012094580A3 (en) | Compounds that modulate oxidative stress | |
EA201690731A1 (en) | ANALYSIS OF IGFBP7, HAVING IMPROVED CHARACTERISTICS IN BIOLOGICAL SPECIMENS | |
DE112009003237A5 (en) | BIOPSY INSTRUMENT FOR ENRICHING SAMPLE MATERIAL | |
CL2013000813A1 (en) | Immunochromatographic device comprising a membrane having an antibody capable of binding to a z-aat protein present in a sample of a piz gene carrier; method for determining a carrier of the piz gene; method to diagnose a condition or disease associated with aat deficiency; immunochromatography kits | |
BRPI0907864A2 (en) | Identification of antigen or ligand-specific binding proteins | |
DK2183599T3 (en) | High-sensitivity immunoassays and kits for the determination of peptides and proteins of biological interest | |
ATE514090T1 (en) | USE OF THE PROTEIN SATB2 AS A MARKER TO DIFFERENTIATE COLORECTAL CARCINOMA FROM OTHER CANCER DISEASES | |
BR112012019475A8 (en) | use of an anti-cd44 monoclonal antibody, anti-cd44 monoclonal antibody, humanized anti-cd44 antibody and kit for detecting hnscc in a sample | |
BR112014031958A2 (en) | bag3 as tissue marker and biochemical serum | |
PE20160657A1 (en) | COMPOSITIONS AND METHODS TO IDENTIFY A RISK OF CANCER IN A SUBJECT | |
EE200600030A (en) | Protein kinase fluorescence probe | |
BRPI1009460A2 (en) | antibody binding domain, antibody, use of a binding domain or antibody, method for detecting the presence of cancer cells in a sample. | |
WO2012145516A3 (en) | Methods and kits for quantitative determination of total organic acid content in a coolant | |
WO2014160273A3 (en) | Protein standard | |
WO2014151290A3 (en) | Assay for predictive biomarkers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12827317 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14238144 Country of ref document: US Ref document number: 2012827317 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2846106 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2014/002051 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2014527346 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2012300319 Country of ref document: AU Date of ref document: 20120824 Kind code of ref document: A |